Search Contract Opportunities

FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement   3

ID: 36C24826Q0337 • Type: Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The Caribbean VA Healthcare System and Orlando VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test, as defined in the Statement of Work (SOW). This will be a Base of 12-months and Four (4) 12-month options. This requirement is solicited as Unrestricted. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511 Medical Laboratories, with a related small business size standard of $41.5 Million, and FSC/PSC is 6640. This solicitation is a Request for Quote (RFQ), for a Firm-Fixed Price (FFP) requirement contract, which will be advertised as unrestricted on or before 26 February 2026, via sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. Amendments to the RFQ will be posted to this website only. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. The contractor must ensure that we receive the proposal on time; NO late proposals will be accepted/ considered. Any questions or concerns regarding this solicitation should be submitted no later than 03/02/2026 at 12:00 PM EST. No further questions will be accepted after that date and time. Please submit questions in writing via e-mail to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov. All quotations for this solicitation shall be submitted no later than 03/09/2026 at 4:00 PM EST. Please submit all responses to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c). *Note* To prepare / complete a Quote, See Offerors Checklist under 52.212-2 Evaluation Commercial Items.
Background
The Caribbean VA Healthcare System and Orlando VA Healthcare System are seeking to procure Thyroid Cancer Molecular Test services. This acquisition is aimed at enhancing the diagnostic capabilities for thyroid cancer, which aligns with the mission of the Department of Veterans Affairs to provide high-quality healthcare to veterans. The contract will be structured as a requirements contract with a base period of 12 months and four additional one-year options.

Work Details
The contractor will provide molecular testing services for thyroid fine-needle aspiration (FNA) specimens with indeterminate cytology (Bethesda III and IV). The required Thyroid Cancer Molecular Test must include:
- Detection of point mutations, gene fusions, copy number variations (CNVs), and other genomic signatures relevant to malignancy risk and treatment decisions.
- Use of next-generation sequencing (NGS) or equivalent high-resolution molecular technology.
- Testing must be performed in a CLIA-certified and CAP-accredited laboratory.
- Reports must include identified genetic variants such as BRAF, RAS, RET/PTC mutations, clinical interpretation, malignancy risk assessment, and references to clinical guidelines.

Estimated quantities for the tests are as follows:
- San Juan: 80 tests per year for the base period; 80 tests for each option year.
- Orlando: 40 tests per year for the base period; 45 tests for option year 1; 50 tests for option years 2-4.

Period of Performance
Base period of 12 months with four (4) additional one-year options.

Place of Performance
VA Caribbean Healthcare System, San Juan, PR; Orlando VA Healthcare System, Orlando, FL.

Overview

Response Deadline
March 9, 2026, 4:00 p.m. EDT Past Due
Posted
Feb. 26, 2026, 4:41 p.m. EST
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
$41.5 Million
Pricing
Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$500,000 - $2,500,000 (AI estimate)
On 2/26/26 VISN 8: Sunshine Healthcare Network issued Solicitation 36C24826Q0337 for FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement due 3/9/26. The opportunity was issued full & open with NAICS 621511 and PSC 6640.
Primary Contact
Title
Contract Specialist
Name
Yolanda H Glover   Profile
Phone
None

Documents

Posted documents for Solicitation 36C24826Q0337

Opportunity Assistant


AI Analysis

AI Generate

Opportunity Lifecycle

Procurement notices related to Solicitation 36C24826Q0337

Award Notifications

Agency published notification of awards for Solicitation 36C24826Q0337

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 36C24826Q0337

Incumbent or Similar Awards

Contracts Similar to Solicitation 36C24826Q0337

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 36C24826Q0337

Similar Active Opportunities

Open contract opportunities similar to Solicitation 36C24826Q0337

Experts for FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > 248-NETWORK CONTRACT OFFICE 8 (36C248)
FPDS Organization Code
3600-00248
Source Organization Code
100167097
Last Updated
May 9, 2026
Last Updated By
Yolanda.Glover@va.gov
Archive Date
May 8, 2026